Spots Global Cancer Trial Database for Descartes-25 in Relapsed/Refractory Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Descartes-25 in Relapsed/Refractory Multiple Myeloma
Official Title: Phase I/IIa Study of Descartes-25 in Patients With Relapsed/Refractory Multiple Myeloma
Study ID: NCT05113342
Interventions
Study Description
Brief Summary: This is a Phase I/IIa dose-escalation study to evaluate the safety, tolerability, and preliminary efficacy of an allogeneic Mesenchymal Stem Cell (Descartes-25) product secreting a bispecific protein and other proteins in patients with Relapsed/Refractory Multiple Myeloma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Louisiana State University Health Science Center at Shreveport, Shreveport, Louisiana, United States
Center for Cancer and Blood Disorders, Bethesda, Maryland, United States
Saglik Bilimleri Universitesi, Ankara, Anatolia, Turkey
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
